Coya Therapeutics CEO Howard Berman's 2023 pay jumps 120% to $1.3M
Coya Therapeutics reports 2023 executive compensation
By ExecPay News
Published: March 28, 2024
Coya Therapeutics reported fiscal year 2023 executive compensation information on March 28, 2024.
In 2023, four executives at Coya Therapeutics received on average a compensation package of $870K, a 35% increase compared to previous year.
Average pay of disclosed executives at Coya Therapeutics
Howard Berman, Chief Executive Officer, received $1.3M in total, which increased by 120% compared to 2022. 44% of Berman's compensation, or $580K, was in salary. Berman also received $254K in bonus and $483K in option awards.
David Snyder, Chief Financial Officer, received a compensation package of $948K, which increased by 56% compared to previous year. 45% of the compensation package, or $425K, was in salary.
Adrian Hepner, Chief Medical Officer, earned $622K in 2023, a 14% decrease compared to previous year.
Fred Grossman, Chief Medical Officer, received $592K in 2023.
Related executives
You may also like
Source: SEC filing on March 28, 2024.